Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare
Collegium Pharmaceutical Inc. Revenue 2016–2025
Collegium Pharmaceutical Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Collegium Pharmaceutical Inc. revenue for the quarter ending March 31, 2026 was 193.5 M, a 8.87% increase year-over-year.
- Collegium Pharmaceutical Inc. revenue for the twelve months ending March 31, 2026 was 768.6 M, a 31.12% increase year-over-year.
- Collegium Pharmaceutical Inc. annual revenue for 2025 was 780.6 M, a 23.62% increase from 2024.
- Collegium Pharmaceutical Inc. annual revenue for 2024 was 631.4 M, a 11.41% increase from 2023.
- Collegium Pharmaceutical Inc. annual revenue for 2023 was 566.8 M, a 22.17% increase from 2022.
- Collegium Pharmaceutical Inc. annual revenue for 2022 was 463.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Collegium Pharmaceutical Inc. Earnings — FAQ
Collegium Pharmaceutical Inc. (COLL) earnings over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COLL's earnings history?
The chart and table above show Collegium Pharmaceutical Inc.'s earnings by year and by quarter, including the growth rate.